GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Earnings per Share (Diluted)

RushNet (RushNet) Earnings per Share (Diluted) : $ (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is RushNet Earnings per Share (Diluted)?

RushNet's Earnings per Share (Diluted) for the three months ended in . 20 was $0.00.

RushNet's EPS (Basic) for the three months ended in . 20 was $0.00.

RushNet's EPS without NRI for the three months ended in . 20 was $0.00.


RushNet Earnings per Share (Diluted) Historical Data

The historical data trend for RushNet's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Earnings per Share (Diluted) Chart

RushNet Annual Data
Trend
Earnings per Share (Diluted)

RushNet Quarterly Data
Earnings per Share (Diluted)

Competitive Comparison of RushNet's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, RushNet's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RushNet's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's PE Ratio distribution charts can be found below:

* The bar in red indicates where RushNet's PE Ratio falls into.



RushNet Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

RushNet's Earnings Per Share (Diluted) for the fiscal year that ended in . 20 is calculated as

Diluted Earnings Per Share (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

RushNet's Earnings Per Share (Diluted) for the quarter that ended in . 20 is calculated as

Diluted Earnings Per Share (Q: . 20 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-)/0
=

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


RushNet  (OTCPK:RSHN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


RushNet Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of RushNet's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


RushNet (RushNet) Business Description

Traded in Other Exchanges
N/A
Address
8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.